CV Company Profile and Key Details

Short-term trend indicators are mixed aligned (SMA20 2.17%, SMA50 -30.78%, SMA200 -9.41%). The stock’s 14-day RSI is 44.37 (neutral), while the ATR of 0.48 points to higher daily volatility. The stock remains hovering near 52-week lows, trading -66.95% below its high and over 47.93% above its low. Average 10-day trading volume of 137.31 thousand shares is below the 3-month average of 259.08 thousand, indicating normal recent market interest.

Analyst sentiment is bullish. Analyst rating data shows there are 3 Strong Buy ratings, 0 Buy ratings, 0 Hold ratings, 0 Sell rating and 0 Strong Sell ratings. Price targets range from $14.00 to $5.00. The high target offers 94.71% upside. The low target suggests -30.46% downside. The mean target is $9.67. This offers 34.49% upside. CapsoVision, Inc. earnings surprise history is a mixed track record. The quarter that ended May 14, 2026, missed forecasts by 15.38%. The prior quarter beat by -8.82%. Over the last six quarters, Apple has recorded several small beats. These include 1736.36% in August 14, 2025.

CapsoVision, Inc. has 46.77 million shares outstanding. This equals 1.99 thousand shares. The short ratio is 0.05 days. Institutional investors hold 0.09% of the float. Insiders own 40.69%.

Our AI price prediction model suggests that CapsoVision, Inc. stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term.

currently trading near 52-week highs band. Valuation shows CapsoVision, Inc. trading at a premium to the broader market with a P/E of -12.66. Analyst sentiment is cautious, with the majority of ratings in Speculative Buy territory and a mean price target of $9.67, suggesting 34.49% upside.

CapsoVision, Inc. last paid a dividend of 0 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around -$2.27. This means the shares are trading below this model’s fair value.

CapsoVision, Inc. trades at a P/E ratio of -12.66, slightly below the S&P 500 average, with a price-to-sales ratio of 26.51 and a price-to-book ratio of 16.89 reflecting a rich premium to book value. The P/FCF stands at -12.37, also below market averages. Compared to sector medians, CapsoVision, Inc. P/S is trading rich, and the P/B is far higher than peers, underscoring the brand and earnings power premium investors assign to the stock.

CapsoVision, Inc. (NASDAQ:CV) closed at $7.19 USD, gaining $0.30 (4.35%) from the previous close of $6.89. The stock is currently mid-range between its 52-week high and low $3.43 and $15.37. With a market capitalization of about $359.24 million, CapsoVision, Inc. is classified as a small-cap and shows lower-than-market volatility (beta ~-2.79). Key stats such as the average daily volume over the past year has been around 254.09 thousand shares, volume is running light vs its 52-week average. Headquartered in Saratoga, CA, CapsoVision, Inc. operates in the Healthcare sector and the Medical - Equipment & Services industry. Led by CEO Kang-Huai Wang, the company employs approximately 90 people and listed since September 03, 2001. CapsoVision, Inc. operates as a medical technology firm, specializing in creating innovative solutions for diagnosing conditions within the gastrointestinal tract.